IGF1R and neoplasm: The presence of IGF-1R expression in the tumor pre-treatment was numerically related to DFS, but this was not significant (HR 0.549, 95% CI 0.276–1.089, P = 0.086) (Fig. 2e), and it was not associated with OS (HR 0.562, 95% CI 0.246–1.285, P = 0.172) (Fig. 2f).